NephU hosts veteran nephrology writer and editor Mark Neumann to discuss a new study looking at diabetes testing and “new” legislation aimed at improving kidney care. Read More
Reduced Health-Related Quality of life (HR-QOL) is experienced by many patients with CKD as the high disease and symptom burden increases. People with CKD also face increased comorbidity symptoms, complications,… Read More
This infographic showcases some of the comparisons between ADPKD, CKD and the general population in regard to hypertension and kidney health. Read More
This article discusses some of the updates released in 2023 by the American Diabetes Association for kidney care. Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.